Development of Drug Substances of the Original Class III Antiarrhythmic Drugs Nibentan and Niferidyl


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Publications on the design, synthesis, pharmacological research, and clinical trials of the Russian original class III antiarrhythmic drugs nibentan {(RS)-4-nitro-N-[1-phenyl-5-(diethylamino)pentyl]benzamide hydrochloride} and niferidyl {4-nitro-N-[(1RS)-1-(4-fluorophenyl)-2-(1-ethylpiperidin-4-yl)ethyl]benzamide hydrochloride}are reviewed.

作者简介

N. Davydova

A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences (INEOS RAN)

编辑信件的主要联系方式.
Email: davydova@ineos.ac.ru
俄罗斯联邦, 28 Vavilova St., Moscow, 119991


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2019
##common.cookie##